Sarcalumenin plays a critical role in age-related cardiac dysfunction due to decreases in SERCA2a expression and activity

Cell Calcium

Volumn 51, Issue 1, 2012, Pages 31-39

  Jiao, Qibin ^a   Takeshima, Hiroshi ^b   Ishikawa, Yoshihiro ^c   Minamisawa, Susumu ^a,c  

^a WASEDA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diastolic function; ER stress; Heart failure; Heart rate variability; Sarcoplasmic reticulum; SERCA2

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; SARCALUMENIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; EXERCISE TOLERANCE; GENE; GENE EXPRESSION REGULATION; HEART FAILURE; HEART FUNCTION TEST; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HEART STRESS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; SARCOPLASMIC RETICULUM; SENESCENCE; SYMPATHETIC TONE; UPREGULATION; WILD TYPE; X BOX BINDING PROTEIN 1 GENE;

MUS;

EID: 84856080791     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.10.003     Document Type: Article

References (27)

1. Haan M.N., Selby J.V., Quesenberry C.P., Schmittdiel J.A., Fireman B.H., Rice D.P. The impact of aging and chronic disease on use of hospital and outpatient services in a large HMO: 1971-1991. J. Am. Geriatr. Soc. 1997, 45:667-674.
2. Weisfeldt M.L. Aging of the cardiovascular system. N. Engl. J. Med. 1980, 303:1172-1174.
3. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol. Rev. 1993, 73:413-467.
4. Kitzman D.W., Little W.C., Brubaker P.H., Anderson R.T., Hundley W.G., Marburger C.T., Brosnihan B., Morgan T.M., Stewart K.P. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002, 288:2144-2150.
5. Cain B.S., Meldrum D.R., Joo K.S., Wang J.F., Meng X., Cleveland J.C., Banerjee A., Harken A.H. Human SERCA2a levels correlate inversely with age in senescent human myocardium. J. Am. Coll. Cardiol. 1998, 32:458-467.
6. Lim C.C., Liao R., Varma N., Apstein C.S. Impaired lusitropy-frequency in the aging mouse: role of Ca(2+)-handling proteins and effects of isoproterenol. Am. J. Physiol. 1999, 277:H2083-H2090.
7. Schmidt U., del Monte F., Miyamoto M.I., Matsui T., Gwathmey J.K., Rosenzweig A., Hajjar R.J. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation 2000, 101:790-796.
8. Schmidt U., Zhu X., Lebeche D., Huq F., Guerrero J.L., Hajjar R.J. In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts. Cardiovasc. Res. 2005, 66:318-323.
9. Leberer E., Charuk J.H., Green N.M., MacLennan D.H. Molecular cloning and expression of cDNA encoding a lumenal calcium binding glycoprotein from sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:6047-6051.
10. MacLennan D.H., Wong P.T. Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 1971, 68:1231-1235.
11. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 2003, 4:566-577.
12. Yoshida M., Minamisawa S., Shimura M., Komazaki S., Kume H., Zhang M., Matsumura K., Nishi M., Saito M., Saeki Y., Ishikawa Y., Yanagisawa T., Takeshima H. Impaired Ca2+ store functions in skeletal and cardiac muscle cells from sarcalumenin-deficient mice. J. Biol. Chem. 2005, 280:3500-3506.
13. Shimura M., Minamisawa S., Takeshima H., Jiao Q., Bai Y., Umemura S., Ishikawa Y. Sarcalumenin alleviates stress-induced cardiac dysfunction by improving Ca2+ handling of the sarcoplasmic reticulum. Cardiovasc. Res. 2008, 77:362-370.
14. Jiao Q., Bai Y., Akaike T., Takeshima H., Ishikawa Y., Minamisawa S. Sarcalumenin is essential for maintaining cardiac function during endurance exercise training. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H576-H582.
15. Yokoyama U., Minamisawa S., Adachi-Akahane S., Akaike T., Naguro I., Funakoshi K., Iwamoto M., Nakagome M., Uemura N., Hori H., Yokota S., Ishikawa Y. Multiple transcripts of Ca2+ channel alpha1-subunits and a novel spliced variant of the alpha1C-subunit in rat ductus arteriosus. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1660-H1670.
16. Yokoyama U., Minamisawa S., Quan H., Ghatak S., Akaike T., Segi-Nishida E., Iwasaki S., Iwamoto M., Misra S., Tamura K., Hori H., Yokota S., Toole B.P., Sugimoto Y., Ishikawa Y. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J. Clin. Invest. 2006, 116:3026-3034.
17. Seely J.E., Poso H., Pegg A.E. Effect of androgens on turnover of ornithine decarboxylase in mouse kidney Studies using labeling of the enzyme by reaction with [14C] alpha-difluoromethylornithine. J. Biol. Chem. 1982, 257:7549-7553.
18. Minamisawa S., Wang Y., Chen J., Ishikawa Y., Chien K.R., Matsuoka R. Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J. Biol. Chem. 2003, 278:9570-9575.
19. Hwang K.J. Interference of ATP and acidity in the determination of inorganic phosphate by the Fiske and Subbarow method. Anal. Biochem. 1976, 75:40-44.
20. Ecker P.M., Lin C.C., Powers J., Kobilka B.K., Dubin A.M., Bernstein D. Effect of targeted deletions of beta1- and beta2-adrenergic-receptor subtypes on heart rate variability. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H192-H199.
21. Goldberg A.L., Stein R., Adams J. New insights into proteasome function: from archaebacteria to drug development. Chem. Biol. 1995, 2:503-508.
22. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 1996, 65:801-847.
23. Jankowska E.A., Ponikowski P., Piepoli M.F., Banasiak W., Anker S.D., Poole-Wilson P.A. Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links. Cardiovasc. Res. 2006, 70:434-445.
24. Yoshida H. ER stress and diseases. FEBS J. 2007, 274:630-658.
25. Hadad N., Meyer H.E., Varsanyi M., Fleischer S., Shoshan-Barmatz V. Cardiac sarcalumenin: phosphorylation, comparison with the skeletal muscle sarcalumenin and modulation of ryanodine receptor. J. Membr. Biol. 1999, 170:39-49.
26. Bers D.M., Despa S., Bossuyt J. Regulation of Ca2+ and Na+ in normal and failing cardiac myocytes. Ann. NY Acad. Sci. 2006, 1080:165-177.
27. Zhao X., Yoshida M., Brotto L., Takeshima H., Weisleder N., Hirata Y., Nosek T.M., Ma J., Brotto M. Enhanced resistance to fatigue and altered calcium handling properties of sarcalumenin knockout mice. Physiol. Genomics 2005, 23:72-78.